Racing to Win: Knocking Out Cancer with Chemotherapy
The race to cure cancer has been a marathon physicians and researchers have been running for decades. But, since the advent of chemotherapeutic treatments, more hurdles are being cleared than ever before. For without surgery and effective, though toxic, drugs to stop cancers in their tracks, many cancer victims might not be the survivors they are today.
Hard work and ingenuity from urology's top innovators ensure that patients have many more options for treatment and cure. Thanks to chemotherapy, some urologic cancers—such as testicular, bladder and Wilms tumor—have a remarkably higher rate of cure.
The most striking chemotherapeutic advances-drugs such as cisplatin, bleomycin and etoposide-have made testicular cancer, the most common malignancy in young men, also the most treatable. A few decades ago, if these "germ cell tumors" had metastasized, the patient usually died. But, today's anti-cancer drugs can produce cures even of the far advanced testicular cancer, remissions